LOEILLOT OLIVIER (Chief Executive Officer) sold 5.9% of their position (3.04K shares) of REPLIGEN CORP on the open market
Open‑market sale worth $503.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/8/2026ACC: 0001628280-26-060911
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-5.88K
Net shares
Net seller
$985.5K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
5.88K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−2.84K
Price / share
$169.61
Trade value
$482.03K
% of position
5.2%
9/3/2026
54.25K→51.40K
Common Stock
Direct
Shares
−3.04K
Price / share
$165.90
Trade value
$503.51K
% of position
5.9%
9/4/2026
51.40K→48.37K
Total
Net shares
−5.88K
Net value
-$985.54K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/3/2026 | F · Tax Withholding | −2.84K | $169.61 | $482.03K | 5.2% | 54.25K | 51.40K |
| Common Stock Direct | 9/4/2026 | S · Sale | −3.04K | $165.90 | $503.51K | 5.9% | 51.40K | 48.37K |
| Total | −5.88K | -$985.54K | ||||||
Derivative Transactions0
No derivative transactions reported